Excellent on time update by ResApp on recruitment in "its SMARTCOUGH-C-2 study which remains on track to complete in the middle of this calendar year".
Indicating an almost 100% quality assurance, strict study protocol, recordings.
Great to hear that "incidenceof the various diseases among study participants has been as expected which should ensure the study generates statistically strong results".I sense Team are highly confident toobtaining great results from the study in the middle of this calendar year and submitting the "de novo application to the US Food and Drug Administration for the world’s first smartphone application for the digital diagnosis of respiratory disease shortly thereafter.”
Thumbs up
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C-2 Study Update
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-32
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
DVP
Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable